749932-68-1

Usage

Uses

Used in Organic Synthesis:
(4-bromo-2-fluorophenoxy)acetonitrile is used as an intermediate in organic synthesis for the production of various chemical compounds.
Used in Pharmaceutical Research:
(4-bromo-2-fluorophenoxy)acetonitrile is used as a research compound in the development of new pharmaceuticals due to its potential biological activities.
Used in Agrochemical Production:
(4-bromo-2-fluorophenoxy)acetonitrile is used as a starting material in the production of agrochemicals.
Used in Drug Development:
(4-bromo-2-fluorophenoxy)acetonitrile is being studied for its potential application in the development of new drugs.
Note: Due to its reactive nature and potential health hazards, proper handling and safety precautions are necessary when working with (4-bromo-2-fluorophenoxy)acetonitrile.

Upstream product

• 2105-94-4 4-bromo-2-fluorophenol 
• 590-17-0 cyanomethyl bromide 

Downstream Products

• 749932-67-0 [4-(3-Cyclopentyl-3-oxo-propyl)-2-fluoro-phenoxy]-acetonitrile 

Relevant academic research and scientific papers

2- PYRIDONE COMPOUND

PROBLEM TO BE SOLVED: To provide a compound that has excellent glucokinase (GK) activating action and is useful as a pharmaceutical. SOLUTION: The present invention provides a 2-pyridone compound represented by formula [1], and a tautomer or stereoisomer of the compound, or their pharmacologically acceptable salts, or their solvates (where R1 is RA-ZA-; RA is any of a carboxy group, a sulfo group or formula [5]). COPYRIGHT: (C)2016,JPOandINPIT

Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same

The invention relates to compounds of the formula 1 and to pharmaceutically acceptable salts, solvates, prodrugs and metabolites thereof, wherein W, Z, R1 and R2, are as defined herein. The invention also relates to methods of treating Hepatitis C virus in mammals by administering the compounds of formula 1, and to pharmaceutical compositions for treating such disorders, which contain the compounds of formula 1. The invention also relates to methods of preparing the compounds of formula 1.

INHIBITORS OF HEPATITIS C VIRUS RNA-DEPENDENT RNA POLYMERASE, AND COMPOSITIONS AND TREATMENTS USING THE SAME

The invention relates to compounds of the formula (I) and to pharmaceutically acceptable salts, solvates, prodrugs and metabolites thereof, wherein W, Z, R1and R2, are as defined herein. The invention also relates to methods of treating Hepatitis C virus in mammals by administering the compounds of formula (I), and to pharmaceutical compositions for treating such disorders, which contain the compounds of formula (I). The invention also relates to methods of preparing the compounds of formula (I).